Podcast


Presenter: James McCormack Pharm D Mike Kolber MD MSc CCFP Tony Nickonchuk BScPharm

In episode 624, James and Mike K invite Tony Nickonchuk to go over all the new evidence we have for the PCSK9 inhibitors. First, we discuss whether or not the evidence addresses the issue of primary versus secondary prevention. We then give you all the numbers and the context you need to allow you to…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

CFP Podcast: Heart of patient-centred care is at home

Join CFP Editor Dr. Nick Pimlott and Associate Editor Dr. David Ponka as they explore the power and the value of seeing patients at home with Dr. Sarah Newbery from…
Listen 0.5 credits available

CFP Podcast: Pourquoi notre système de santé est-il toujours en crise? (Français)

Pour quiconque pratique la médecine de famille au Canada depuis un certain temps, il peut sembler que notre système de santé passe constamment d’une crise à l’autre : urgences surchargées,…
Listen 0.5 credits available

CFP Podcast: Sharing a habitat with our patients: interview with Dr. Sarah Barclay

Dr. Sarah Barclay arrived in the community of Stouffville, ON in 2002 as a young family medicine resident studying at Queen’s University in Kingston, ON, never expecting to return. But…
Listen 0.5 credits available

Presenter(s):

James McCormack Pharm D Mike Kolber MD MSc CCFP Tony Nickonchuk BScPharm

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • James McCormack Pharm D
  • Mike Kolber MD MSc CCFP
  • Tony Nickonchuk BScPharm

Speakers do not have any conflicts of interest to declare.